The Role of Comprehensive Eye Exams in the Early Detection of Diabetes and Other Chronic Diseases in an Employed Population
|
|
- Caitlin Booker
- 5 years ago
- Views:
Transcription
1 POP Schaneman_1P.3D 03/15/10 6:21pm Page 1 POPULATION HEALTH MANAGEMENT Volume 00, Number 00, 2010 ª Mary Ann Liebert, Inc. DOI: =pop POP Schaneman_1P Type: research-article Original Article The Role of Comprehensive Eye Exams in the Early Detection of Diabetes and Other Chronic Diseases in an Employed Population Justin Schaneman, M.S., Amy Kagey, M.S., Stephen Soltesz, B.S., and Julie Stone, B.S. Abstract Objective: The main objective of this study is to assess the cost benefit associated with comprehensive eye exams as a tool for the early detection of diabetes, hypertension, and high-cholesterol. Methods: A retrospective, claims-based analysis was performed using U.S.-based employees and spouses from a large, national database. Individuals that received first notification of disease through an eye exam were compared to individuals that did not receive early detection and presumably learned of their condition after further disease progression. Total health plan costs, lost time costs, and termination rates were calculated for the 12- month period after the index date. Results: A sizeable population first learned of their chronic condition through eye exams as no other claimsbased evidence was found to suggest prior knowledge of the condition. All three disease cohorts with early detection during an eye exam had lower first-year health plan costs, missed fewer work days, and were less likely to terminate employment than the respective comparison groups. Conclusion: As employers strive to better manage health and business outcomes, comprehensive eye health exams can provide opportunity for early disease detection and associated cost savings through referral to primary care providers and condition management programs. (Population Health Management 2010;13:xx xx) Introduction As health care costs continue to rise at alarming rates 1,2 and businesses are left with shrinking profit margins during an unsure economy, employers are actively seeking new solutions to the health care cost and quality problem. Early disease detection has long been proposed as part of this solution, but traditional condition management interventions typically get involved significantly after the onset of symptoms. Accordingly, opportunities to improve outcomes are limited since much of the associated risk has already manifested itself in terms of poor health outcomes and high costs. This study will evaluate the role of comprehensive eye exams as a potential tool for more focused and proactive chronic disease detection that allows intervention further upstream in an individual s disease progression. In addition to eye-specific diseases, routine eye exams are capable of early identification of conditions such as diabetes, hypertension, and high cholesterol levels. 3 6 Literature suggests the early identification of all three of these diseases can lead to better management of conditions, avoid related complications, and reduce costs. 7 9 As such, comprehensive eye exams have the potential to play a significant role in health care cost management strategies. For the purposes of assessing the benefit of early disease detection through eye exams, a group of individuals that first learned of their disease through a comprehensive eye exam provided by an optometrist was evaluated against a comparison group of like individuals who learned of their disease through other means. Again, the study focuses on three specific diseases that are identifiable through routine eye exams: diabetes, hypertension, and corneal arcus (an indication of high cholesterol). Methods Data A retrospective study was performed using the Human Capital Management Services Reference Research Database (RRDb). The RRDb contains demographic, employment, compensation, medical claims, pharmacy claims, disability, Human Capital Management Services, Cheyenne, Wyoming. Funding was provided by VSP Vision Care, Rancho Cordova, California. 1
2 POP Schaneman_1P.3D 03/15/10 6:21pm Page 2 2 SCHANEMAN ET AL. workers compensation, and absence data sources from numerous large employers throughout the United States. To supplement data already available in the RRDb, vision claims data were provided by VSP Vision Care (VSP). Population The following parameters were used to define the analysis populations: The Study Group: Includes employees and spouses with a comprehensive eye exam that identified the presence of diabetes, hypertension, or high cholesterol for the first time. As part of the eye exam process, doctors can explicitly identify the presence of a given disease by checking the appropriate box on a screening form that accompanies the billing form used by the insurance company. Alternatively, as screening forms are not consistently provided by all eye doctors, this study also attempts to include individuals with an early disease detection even if the accompanying form was not filled out. To this end, individuals who enter the medical system for a given disease shortly after an eye exam are included in this cohort under three assumptions: 1. If the disease was diagnosed through traditional methods within a short period of time following an eye exam, early evidence of the disease would have been noticeable at the time of the eye exam. 10,11 2. The eye exam itself was likely the catalyst for the individual to learn of the disease and to enter the medical system. 3. As such, individuals with a medical or pharmacy claim for a given disease within 180 days of an eye exam are included in the study group. The length of this window was based on the median time to enter the medical system for those individuals where a screening form was available. The Comparison Group: Includes employees and spouses with a new onset of diabetes, hypertension, or high cholesterol with no evidence of an eye exam that could have led to the identification. Index Date: The first indication of disease found in vision, medical, or pharmacy claims data. For individuals in the study group, the index date represents the date of an eye exam. For individuals in the comparison group, the index date represents the date of a medical or pharmacy claim for the given disease. Exclusions: Individuals who were over the age of 65 were excluded, as Medicare data was not available for this population. Additionally, individuals with over $400,000 in total health plan cost (medical cost þ pharmacy cost) were also excluded based on an outlier analysis. Time Period: The study includes individuals with an index date between July 1, 2006 and June 30, Individuals must have been enrolled in a health plan with available data for the 6-month period preceding the index date. Similarly, for health plan and lost-time outcomes, individuals must have been enrolled for the full 12 months following the index date. For analyses related to termination, only s6months of enrollment was required after the index date. Wash-Out Period: All cohorts are subject to a 6-month wash-out period before their index date as the study is designed to capture new disease onset. Individuals with data-based evidence of the disease prior to the index date are excluded. ICD-9 codes used for disease definition: 1. Within the medical claims data, the presence of a disease was measured with the presence of a diseasespecific primary, secondary, or tertiary ICD-9 code from the International Classification of Diseases, 9 th Revision. 2. Diabetes: ICD-9 codes of 250.xx 251.xx. 3. Hypertension: ICD-9 codes of 401.xx 405.xx and 437.2x. 4. High cholesterol: ICD-9 codes of 272.xx and NDC codes used for disease definition: 1. Within the pharmacy claims data, the presence of a disease was measured with the presence of a diseasespecific drug class based on the National Drug Classification (NDC) code. 2. Diabetes: Drug classes containing insulin, alphaglucosidase inhibitors, antidiabetic combinations, meglitinides, miscellaneous antidiabetic agents, nonsulfonylureas, sulfonylureas, and thiazolidinediones. 3. Hypertension: Drug classes containing antihypertensives, alpha agonists=alpha blockers, beta blockers, calcium channel blockers, ace inhibitors, and diuretics. 4. High cholesterol: Drug class containing hyperlipidemia. Analytic questions Three primary comparisons are made in the study and replicated for each disease cohort: 1. Evaluation of the study group (with early disease detection through an eye exam) against a comparison group in terms of first-year health plan spending following disease identification. Medical and pharmacy costs for the disease of interest are considered along with medical and pharmacy costs for co-morbid conditions. 2. Evaluation of the study group against a comparison group in terms of lost time cost due to short-term disability, long-term disability, and workers compensation episodes. Both long-term disability and workers compensation costs include costs paid-to-date plus reserved costs expected to be paid in the future on claims that remain open. Short-term and long-term disability costs represent income replacement costs paid to workers when they are unable to be on the job. Workers compensation costs include both medical and income replacement costs. Only employees are included in this analysis as lost time data was only available for the employee population. 3. Evaluation of the study group against a comparison group in terms of termination rates following disease onset. Again, only employees and not their spouses are included in this analysis. Statistics analysis Data analysis was generated by the SAS software platform Version For the comparison of health plan costs addressed in Analytic Question 1, a two-part regression technique was used to estimate disease-specific medical
3 POP Schaneman_1P.3D 03/15/10 6:21pm Page 3 COMPREHENSIVE EYE EXAMS IN EARLY DISEASE DETECTION 3 costs, co-morbid medical costs, and drug costs for the study and comparison groups. Health plan cost data is typically right-skewed with a large proportion of valid zeroes. As such, the two-part regression model approach was chosen and is commonly used for health plan data modeling. 12,13 The first part used a logistic regression model to predict the probability that cost was greater than zero. The second part used a generalized linear model (GLM) with a log link and a gamma distribution to conditionally predict cost for those with cost greater than zero. A dichotomous variable was created to distinguish between the study group and the comparison group. Various sets of model-appropriate control variables were constructed to adjust for differences in the groups not explained by the group indicator variable. These include age, gender, indicator for employee or spouse, company, Charlson co-morbidity score, 14 prior and concurrent medication utilization (when predicting nonpharmacy medical costs), and the number of unique medical providers (when predicting pharmacy costs). Lost-time costs, as described in Analytic Question 2, were also estimated with the same two-part regression approach as outlined above. To assess the difference in termination rates for each group as described in Analytic Question 3, a Kaplan Meier survival curve approach was used to adjust for censored observations. Using available termination dates in the data, the time in days to termination (or end of available data for those still employed) from the individual s first disease detection date was calculated. A Kaplan Meier curve was then derived for both the study group and the comparison group. The estimated termination percents were compared between groups at time equal to 365 days. The nonparametric log-rank test was used to assess statistical difference between the two survival curves. Results Analytic Question 1 Total health plan costs (disease specific medical þ comorbid medical cost þ pharmacy cost) were consistently lower for the study group across all three disease cohorts. The diabetes cohort displayed the greatest cost savings T1 c ($6465 vs. $7251, Table 1). The hypertension ($5829 vs. $6015, T2 T3 c Table 2) and high cholesterol ($4147 vs. $4192, Table 3) cohorts also exhibited positive findings. Analytic Question 2 All three disease cohorts exhibited lower lost time costs due to short-term disability, long-term disability, and workers compensation in the study group, suggesting that detection of the disease during the eye exam potentially leads to fewer lost work days. The high cholesterol cohort showed the greatest cost savings ($256 vs. $320, P ¼ 0.04, see Table 3), while the diabetes ($449 vs. $459, P ¼ 0.91, see Table 1) and hypertension ($548 vs. $555, P ¼ 0.91, see Table 2) cohorts displayed smaller positive, but insignificant results. Analytic Question 3 Using the Kaplan Meier estimate of the survival function, the hypertension cohort displayed the greatest statistically significant difference in termination rates within one year of disease detection between the two groups (9.5% vs. 13.4%, P < 0.005, see Table 2). Similarly, the diabetes cohort (8.5% vs. 11.5%, P ¼ 0.31, see Table 1) and the high cholesterol cohort (8.5% vs. 9.8%, P ¼ 0.06, see Table 3) had positive results for the study group, but sample sizes were not large enough to suggest a statistical difference in the survival curves of the study group and the comparison group. Limitations Significant effort was made to control for confounding factors and differences between groups; however, it is possible that some of the effect is driven by variables not available in the study. It is also possible that individuals in the study group are inherently earlier in their disease progression than individuals in the comparison group. While getting to individuals as early as possible is a positive outcome in itself, a follow-up analysis with more longitudinal data may be able to confirm that the cost differences seen in this study persist into future years and are not an artifact of this particular study design. Finally, since the screening form for early disease detection was not consistently available, the study had to use claims-based criteria as evidence of early disease detection in many cases. These criteria logically link claims activity to an eye exam, but may not be precise in every circumstance. Discussion Individuals who receive an early detection of their chronic disease through an eye exam exhibited lower total health plan costs, lower costs due to lost-time, and a lower rate of termination during the 12 months following the first evidence of the disease. These results were consistent for all three disease cohorts. As seen in Table 4, after totaling the per-person savings for the entire study group, a savings of roughly 4.5 million dollars was observed. To put this number into perspective, the total eye exam fees for all covered members (including b T4 Table 1. Diabetes Outcome Metric Study Group Comparison Group P-value Health Plan Cost $6465 (N ¼ 620) $7251 (N ¼ 2668) Disease-specific medical cost $495 $836 <0.005 Comorbid medical cost $4449 $ Pharmacy cost $1521 $ Lost Time Cost $449 (N ¼ 401) $459 (N ¼ 1696) 0.91 Percent Terminated 8.5% (N ¼ 400) 11.5% (N ¼ 1773) 0.31
4 POP Schaneman_1P.3D 03/15/10 6:21pm Page 4 4 SCHANEMAN ET AL. Table 2. Hypertension Outcome Metric Study Group Comparison Group P-value Health Plan Cost $5829 (N ¼ 1558) $6015 (N ¼ 17,122) Disease-specific medical cost $409 $801 <0.005 Comorbid medical cost $4262 $ Pharmacy cost $1158 $1312 <0.005 Lost Time Cost $548 (N ¼ 997) $555 (N ¼ 11,707) 0.91 Percent Terminated 9.5% (N ¼ 1012) 13.4% (N ¼ 12,248) <0.005 Table 3. High Cholesterol Outcome Metric Study Group Comparison Group P-value Health Plan Cost $4147 (N ¼ 2824) $4192 (N ¼ 12,059) Disease-specific medical cost $235 $272 <0.005 Comorbid medical cost $2988 $ Pharmacy Cost $924 $ Lost Time Cost $256 (N ¼ 1909) $320 (N ¼ 8200) 0.04 Percent Terminated 8.5% (N ¼ 1931) 9.8% (N ¼ 8596) 0.06 Table 4. Study Group Cost Savings Savings Category Disease Study Group Comparison Group Difference (per person) Study Group N Savings Health Plan Cost Diabetes $6465 $7251 $ $466,098 Hypertension $5829 $6015 $ $278,814 High cholesterol $4147 $4192 $ $122,580 Lost Time Cost Diabetes $449 $459 $ $3850 Hypertension $548 $555 $7 997 $6713 High cholesterol $256 $320 $ $117,632 Turnover Diabetes 8.5% 11.5% 3.0% 400 $555,134 Hypertension 9.5% 13.4% 3.9% 1012 $1,825,837 High cholesterol 8.5% 9.8% 1.3% 1931 $1,134,496 Total $4,511,154 those with and without an early disease detection) during this time period was approximately 4.8 million dollars. So, in addition to the core benefit provided in terms of vision improvements, the eye exams returned approximately $0.94 for every $1.00 spent from the benefit of early disease detection. The $0.94 return is composed of $0.18 due to health plan cost reductions, $0.03 for reductions in lost-time, and $0.73 for reductions in termination rates. The termination rate estimate was converted to a cost using a wage replacement value of 60% of base salary based on J. Phillips Investing in Your Company s Human Capital. 15 Conclusion This analysis gives evidence that early detection of chronic disease through comprehensive eye exams can lead to lower health plan costs, fewer lost work days, and lower rates of termination. In fact, cost savings almost completely offset the fees of the eye exams. As such, employers should consider eye exams as part of their overall health strategy and should seek eye care providers who offer eye health exams in a broad and effective manner, and who are capable of referring cases of early detection to primary care and condition management. Emerging research suggests that primary care, as opposed to specialty care, can provide higher quality and more cost effective care for those in the beginning stages of chronic disease. Finally, despite chronic disease screenings being available inside traditional insurance coverage, these tools are underutilized by patients and doctors in the formal setting. 16 The cost savings found in this study were made possible by comprehensive eye exams that are typically not available through traditional health insurance, but instead as an addon benefit largely funded directly by employees themselves. Competitive market environments, as well as the direct purchase nature of eye exam services, strengthen consumer engagement and discretionary participation in preventive services in a way not seen with traditional medical insurance coverage. Author Disclosure Statement No competing financial interests exist. References 1. Bodenheimer T. High and rising health care costs. Part 1: Seeking an explanation. Ann Intern Med 2005;142: b AU1
5 POP Schaneman_1P.3D 03/15/10 6:21pm Page 5 COMPREHENSIVE EYE EXAMS IN EARLY DISEASE DETECTION 5 2. Orszag P, Ellis P. The challenge of rising health care costs A view from the Congressional Budget Office. N Engl J Med 2007;357: Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol 2005; 40: Xu L, Wang YX, Jonas JB, Wang YS, Wang S. Ocular hypertension and diabetes mellitus in the Beijing Eye Study. J Glaucoma 2009;18: Lertchavanakul A, Laksanaphuk P, Tomtitchong T. Corneal arcus associated with dyslipidemia. J Med Assoc Thai 2002;85:231S 235S. 6. Chua BE, Mitchell P, Wang JJ, Rochtchina E. Corneal arcus and hyperlipidemia: Findings from an older population. Am J Ophthalmol 2004;137: The CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA 1998;280: van Buuren S, Boshuizen HC, Reijneveld SA. Toward targeted hypertension screening guidelines. Med Decis Making 2006;26: Sullivan DR. Screening for cardiovascular disease with cholesterol. Clin Chim Acta 2002;315: Nishimoto J, Townsend J, Selvin G, De Land P. Corneal arcus as an indicator of hypercholesterolemia. J Am Optom Assoc 1990;61: Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4 7 yr before clinical diagnosis. Diabetes Care 1992;15: Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ 1999;18: Mullahy J. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998;17: Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: Phillips J. Investing in your company s human capital. New York: AMACOM, 2005: U.S. Preventive Services Task Force. Guide to clinical preventive services, periodic updates. Rockville (MD): Agency for Healthcare Research and Quality, Address correspondence to: Justin Schaneman, M.S. Human Capital Management Services 1800 Carey Avenue, Suite 300 Cheyenne, WY justin_schaneman@hcmsgroup.com
6 POP Schaneman_1P.3D 03/15/10 6:21pm Page 6
7 POP Schaneman_1P.3D 03/15/10 6:21pm Page 7 AUTHOR QUERY FOR POP SCHANEMAN_1P AU1: Is Disclosure Statement accurate? If not, please amend as needed.
VISION CARE INVESTMENT PAYS BIG BENEFITS.
VSP WHITE PAPER VISION CARE INVESTMENT PAYS BIG BENEFITS. Study shows a 127% return on investment with VSP Vision Care. EXECUTIVE SUMMARY An investment in VSP vision coverage can lower overall healthcare
More informationDental insurance: A bright idea for your business
Dental insurance: A bright idea for your business Many challenges, one solution Your business faces a variety of challenges every day. Fortunately, you can solve many of them through one solution: offering
More informationGSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationReal World Patients: The Intersection of Real World Evidence and Episode of Care Analytics
PharmaSUG 2018 - Paper RW-05 Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics David Olaleye and Youngjin Park, SAS Institute Inc. ABSTRACT SAS Institute recently
More informationCost-Motivated Treatment Changes in Commercial Claims:
Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical
More informationThe University of Mississippi School of Pharmacy
LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 6: Medicare Expenditures for Persons With CKD Medicare spending for patients with CKD aged 65 and older exceeded $50 billion in 2013, representing 20% of all
More informationInsurance Guide For Dental Healthcare Professionals
Insurance Guide For Dental Healthcare Professionals Dental Benefits Basics What is dental insurance? Unlike traditional insurance, dental benefits are not meant to cover all oral healthcare needs. The
More informationChapter 6: Healthcare Expenditures for Persons with CKD
Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial
More informationLarge Scale Predictive Analytics for Chronic Illness using FuzzyLogix s In-Database Analytics Technology on Netezza
Large Scale Predictive Analytics for Chronic Illness using FuzzyLogix s In-Database Analytics Technology on Netezza Christopher Hane, Vijay Nori, Partha Sen, Bill Zanine Fuzzy Logix Contact: Cyrus Golkar,
More informationCOMMITMENT TO A TOBACCO ENDGAME IN ONTARIO
COMMITMENT TO A TOBACCO ENDGAME IN ONTARIO Our Ask That the Ontario government: Renew their commitment to achieving the lowest smoking rate in Canada Align the Smoke Free Ontario Strategy with the proposed
More informationKeep employees healthy through smart technology.
Keep employees healthy through smart technology. BIOMETRICS SOFTWARE INSIGHT Healthy employees. Healthy company. Investing in your employees health is one of the wisest decisions you can make. The TruSense
More informationPropensity Score Matching with Limited Overlap. Abstract
Propensity Score Matching with Limited Overlap Onur Baser Thomson-Medstat Abstract In this article, we have demostrated the application of two newly proposed estimators which accounts for lack of overlap
More informationThe Impact of Hepatitis-C Viral (HCV) Treatment on Work Absence and Productivity
Jun Su, athan L. Kleinman 2, Richard A. Brook 3, Arthur K. Melkonian 4, Jim Smeeding 5, Patricia Corey-Lisle Global Outcomes Research, Bristol-Myers Squibb, Wallingford, CT, USA. 2 HCMS Group, Paso Robles,
More informationStatus of the CKD and ESRD treatment: Growth, Care, Disparities
Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator
More informationSpending estimates from Cancer Care Spending
CALIFORNIA HEALTHCARE FOUNDATION August 2015 Estimating Cancer Care Spending in the California Medicare Population: Methodology Detail This paper describes in detail the methods used by Deborah Schrag,
More informationJukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at:
Hospital to Retail Spillover Analysis and Its Impact on Commercial Decision Making Jukti Kumar Kalita, PhD Business Analytics and Insights Pfizer Presented at: 1 Disclaimer The information provided and
More informationDo OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018
Question: Do OurHealth primary care clinics improve health & reduce healthcare costs? OurHealth Patient Engagement Analysis June 2018 An examination of health improvements, utilization & cost of care for
More informationThe Value of Providing Collaborative Care Models For Treating Employees with Depression
The Value of Providing Collaborative Care Models For Treating Employees with Depression Summary Depression is one of the costliest health issues for employers because of its high prevalence and co-morbidity
More informationEvidence-Based Population Health Management through Analytics
Evidence-Based Population Health Management through Analytics Presented to: Human Factor Analytics, Inc. Slide 1 What can a geological principle teach us about risk management? Human Factor Analytics,
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationACO Lunch & Learn ICD 10.Are you ready? March 18, 2015
ACO Lunch & Learn ICD 10.Are you ready? March 18, 2015 ACO Announcements GPRO CMS reviews have come to a close! Reminders: ACO Notifications PQRS ICD-10-CM The importance of complete and accurate documentation
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationCare Facilitation Quality Improvement Report
Disease Management Program Clinical Outcomes for Reporting Period: 2006 Diabetes 100.0% 90.0% % of participants with diabetes 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% % participants with at
More informationThe Cost Of Functional Dyspepsia Results From A Large US Employer Database
European ISPOR Meeting Copenhagen, Denmark October 30, 2006 The Cost Of Functional Dyspepsia Results From A Large US Employer Database Researchers: Stephen George, MS, RPh 1, Nathan Kleinman, PhD 2, Richard
More informationComparative Analysis of Individuals With and Without Chiropractic Coverage Patient Characteristics, Utilization, and Costs
Comparative Analysis of Individuals With and Without Chiropractic Coverage Patient Characteristics, Utilization, and Costs 1 Archives of Internal Medicine. October 11, 2004;164:1985-1992 Antonio P. Legorreta,
More informationTHE ECONOMIC BURDEN OF DIABETIC MACULAR EDEMA IN A WORKING AGE AND COMMERCIALLY INSURED POPULATION. Christopher John Wallick
THE ECONOMIC BURDEN OF DIABETIC MACULAR EDEMA IN A WORKING AGE AND COMMERCIALLY INSURED POPULATION Christopher John Wallick A thesis submitted in partial fulfillment of the requirements for the degree
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationIssue Brief. Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact. Introduction. Background
Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact Introduction In 2009, California eliminated non-emergency dental services for adults in its Medicaid program, Medi-Cal. The California
More informationUsing claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center
Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.
More informationpaint a realistic picture of your organization s health
plan analytics paint a realistic picture of your organization s health Impressionism has no place in your health care benefit plan. Arm yourself with the facts. Uses up-to-date client-specific data Clears
More informationLike others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.
Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union
More informationYour Partnership in Health Report: Chronic Conditions ABC Company and Kaiser Permanente
Your Partnership in Health Report: s ABC Company and Kaiser Permanente Measurement Period: JUL-01-2012 through JUN-30-2013 Report Date: DEC-31-2013 Commercial All Members Partnership in Health (PIH) reports:
More informationHEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES
HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Presented by Parul Agarwal, PhD MPH 1,2 Thomas K Bias, PhD 3 Usha Sambamoorthi,
More informationUnitedHealth Premium Designation Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment
UnitedHealth Premium Designation Program Case-mix Adjusted Benchmarks with Severity or Risk Adjustment Resources u Phone: 866-270-5588 u u u Website: UnitedHealthcareOnline.com > Quick Links > UnitedHealth
More informationType 2 Diabetes: Incremental Medical Care Costs During the 8 Years Preceding Diagnosis. Diabetes Care 23: , 2000
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Type 2 Diabetes: Incremental Medical Care Costs During the 8 Years Preceding Diagnosis GREGORY A. NICHOLS, PHD HARRY S.
More informationComparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments
Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,
More informationSolving for Type 2 Diabetes in the Workplace
TEXAS BUSINESS GROUP ON HEALTH Solving for Type 2 Diabetes in the Workplace Bharath Thankavel, MD Medical Director, Value Based Care Blue Cross and Blue Shield of Texas @BCBSTX Blue Cross and Blue Shield
More informationCommunity Health Workers Make Cents: A return on investment analysis MHP SALUD WORKS TO UNDERSTAND THE FINANCIAL IMPACT OF COMMUNITY HEALTH WORKERS
Community Health Workers Make Cents: A return on investment analysis MHP SALUD WORKS TO UNDERSTAND THE FINANCIAL IMPACT OF COMMUNITY HEALTH WORKERS Overview Background Literature Methods Results Conclusion
More informationICD-10CM, HCC and Risk Adjustment Factor
ICD-10CM, HCC and Risk Adjustment Factor Not everyone is aware of what CMs calls the risk adjustment model. It was developed under the Patient Protection and Affordable Care Act (also known as the PACA)
More informationPer Capita Health Care Spending on Diabetes:
Issue Brief #10 May 2015 Per Capita Health Care Spending on Diabetes: 2009-2013 Diabetes is a costly chronic condition in the United States, medical costs and productivity loss attributable to diabetes
More informationAPPENDIX: Supplementary Materials for Advance Directives And Nursing. Home Stays Associated With Less Aggressive End-Of-Life Care For
Nicholas LH, Bynum JPW, Iwashnya TJ, Weir DR, Langa KM. Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia. Health Aff (MIllwood).
More informationA COMPREHENSIVE REPORT ISSUED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS IN PARTNERSHIP WITH:
A COMPREHENSIVE REPORT ISSUED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS IN PARTNERSHIP WITH: Amputee Coalition of America Mended Hearts National Federation of the Blind National Kidney Foundation
More informationAddressing the rapid rate of change in the DOT-regulated world
DOT Regulations Addressing the rapid rate of change in the DOT-regulated world Health care trends affecting today s commercial vehicle drivers and their companies June 2016 Today there is a heightened
More informationEffectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
University of Rhode Island DigitalCommons@URI Senior Honors Projects Honors Program at the University of Rhode Island 2009 Effectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
More informationDIABETES ASSOCIATED WITH ANTIPSYCHOTIC USE IN VETERANS WITH SCHIZOPHRENIA
DIABETES ASSOCIATED WITH ANTIPSYCHOTIC USE IN VETERANS WITH SCHIZOPHRENIA Fran Cunningham, Pharm.D. Department of Veterans Affairs* University of Illinois at Chicago Bruce Lambert, Ph.D. University of
More informationEconomics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol
s of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol Summary Evidence Tables Study Author (Year) Bunting (2008) Prepost Incomplete
More informationThe Potential For Teleophthalmology in the Patient-Centered Medical Home Model
The Potential For Teleophthalmology in the Patient-Centered Medical Home Model Christina Sheppler, PhD Legacy Research Institute Devers Eye Institute NRTRC Telemedicine Conference March 26, 2014 Disclosures
More informationInsights from the Clalit Health Services database about Psoriasis Research using BIG DATA Arnon D. Cohen, MD, MPH, PHD
Insights from the Clalit Health Services database about Psoriasis Research using BIG DATA Arnon D. Cohen, MD, MPH, PHD Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences,
More informationEstimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach
Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Presented by Susan G. Haber, Sc.D 1 ; Boyd H. Gilman, Ph.D. 1 1 RTI International Presented at The 133rd Annual Meeting of
More informationTrends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation,
Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017 Junya Zhu, PhD Department of Health Policy and Management January 23, 2018 Acknowledgments Co-Authors G.
More informationWhat Have We Learned from Economic Analyses of Prevention?
What Have We Learned from Economic Analyses of Prevention? Louise B. Russell, PhD Economics of Prevention Workshop Sydney, Australia March 13, 2009 The Prevention Agenda Australia: Investing more in health
More informationLeveraging Data for Targeted Patient Population Health Improvements
Leveraging Data for Targeted Patient Population Health Improvements Diabetes Impact on Health in America Diabetes is a major health concern in the United States today. The Centers for Disease Control
More informationImproving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help
Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org
More informationRisk of Fractures Following Cataract Surgery in Medicare Beneficiaries
Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries Victoria L. Tseng, MD, Fei Yu, PhD, Flora Lum, MD, Anne L. Coleman, MD, PhD JAMA. 2012;308(5):493-501 Background Visual impairment
More informationUnderstanding the Value of Generic Drugs
Understanding the Value of Generic Drugs Generic drugs can help you get the most out of your health care budget. 05.02.306.1 (8/05) Many people believe that when something costs more, it must be of higher
More informationReducing Tobacco Use and Secondhand Smoke Exposure: Reducing Out-of-Pocket Costs for Evidence Based Tobacco Cessation Treatments
Reducing Tobacco Use and Secondhand Smoke Exposure: Reducing Out-of-Pocket Costs for Evidence Based Tobacco Cessation Treatments Task Force Finding and Rationale Statement Table of Contents Intervention
More informationRisk adjustment in health care markets: concepts and applications. Randall P. Ellis. Boston University and DxCG, Inc.
Risk adjustment in health care markets: concepts and applications Randall P. Ellis. Boston University and DxCG, Inc. Slides prepared for the Risk Adjustment Network (RAN) meeting in Dublin Ireland, March
More informationVisualizing Data for Hypothesis Generation Using Large-Volume Health care Claims Data
Visualizing Data for Hypothesis Generation Using Large-Volume Health care Claims Data Eberechukwu Onukwugha PhD, School of Pharmacy, UMB Margret Bjarnadottir PhD, Smith School of Business, UMCP Shujia
More informationPrescription Switching and Reduced LDL-C Goal Attainment
Prescription Switching and Reduced LDL-C Goal Attainment JoAnne M. Foody, MD, FACC, FAHA Brigham and Women's Hospital, Boston, MA Disclosures Consultant for Merck and Pfizer Why Address Adherence? Increasing
More informationPOSITION STATEMENT ON HEALTH CARE REFORM NADP PRINCIPLES FOR EXPANDING ACCESS TO DENTAL HEALTH BENEFITS
POSITION STATEMENT ON HEALTH CARE REFORM THE NATIONAL ASSOCIATION OF DENTAL PLANS (NADP) is the nation s largest association of companies providing dental benefits. NADP members cover 136 million Americans
More informationPayers continue to search for effective ways to control
At a Glance Practical Implications p 218 Author Information p 221 Full text and PDF www.ajpblive.com Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes Benefit
More informationDuring the last decade, disease management has. Asthma Disease Management: Regression to the Mean or Better? MANAGERIAL
Asthma Disease Management: Regression to the Mean or Better? David Tinkelman, MD; and Steve Wilson, MA Objectives: To assess the effectiveness of disease management as an adjunct to treatment for chronic
More information. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationElectronic Documentation of Lifestyle Counseling and Glycemic Control in Patients with Diabetes
Electronic Documentation of Lifestyle Counseling and Glycemic Control in Patients with Diabetes Naoshi Hosomura, DDS, DMSc 1, Saveli I Goldberg, PhD 2, Mary Zhang, MA 1, Maria Shubina, ScD 1, Alexander
More informationFinal Report DIABETES VALUE METRIC. valueworks. Executive summary. The need for a measure of value
DIABETES VALUE METRIC Final Report A participant in the Robert Wood Johnson Foundation s Aligning Forces for Quality initiative to improve health and health care in Wisconsin. valueworks measure enlighten
More informationChapter 2: Identification and Care of Patients with CKD
Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationImpact of Eliminating Medicaid Adult Dental Coverage in California on Emergency. Department Use for Dental Problems
Impact of Eliminating Medicaid Adult Dental Coverage in California on Emergency Department Use for Dental Problems Introduction: Oral health is an integral part of overall well-being. Apart from having
More informationFolland et al Chapter 4
Folland et al Chapter 4 Chris Auld Economics 317 January 11, 2011 Chapter 2. We won t discuss, but you should already know: PPF. Supply and demand. Theory of the consumer (indifference curves etc) Theory
More informationWebinar Series: Diabetes Epidemic & Action Report (DEAR) for Washington State - How We Are Doing and How We Can Improve.
Webinar Series: Diabetes Epidemic & Action Report (DEAR) for Washington State - How We Are Doing and How We Can Improve April 22, 2015 Qualis Health A leading national population health management organization
More informationImpact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost Medical Care. 2005;43:521-530. Presented by Rodger Kormylo to the ACSW 11/10/2005 Medco is a registered trademark of Medco Health
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationThe Journey towards Total Wellbeing A Health System s Innovative Approach
The Journey towards Total Wellbeing A Health System s Innovative Approach Company Profile Wellness A state of complete physical, mental and social wellbeing and not merely the absence of disease or infirmity
More informationVoluntary Dental. Tiered Approach. An independent licensee of the Blue Cross and Blue Shield Association. 28XX1361 R04/07
Voluntary Dental Tiered Approach An independent licensee of the Blue Cross and Blue Shield Association. Affordable protection for employees and their families 28XX1361 R04/07 Direct to You...Voluntary
More informationAppendix B Medical Classification System Basics. (Formerly DxCG, Inc.)
Appendix B Medical Classification System Basics (Formerly DxCG, Inc.) 1 Overview: Medical Classification System (version 7 ) Aggregated Condition Categories (ACC): 31 Least detail Related Condition Categories
More informationMental Illness and Addiction:
Mental Illness and Addiction: Impact on the Workforce Presented by Terri White, MSW Commissioner Oklahoma Department of Mental Health and Substance Abuse Services Mental Illness and Addiction: Diseases
More informationAlabama Medicaid Pharmacy Override
Alabama Medicaid Pharmacy Override Therapeutic Duplication, Early Refill, Maximum Unit, Prescription Limit Switchover, Dispense as Written, Accumulation Edit, Maintenance Supply Opt Out, and Maximum Cost
More informationType 2 diabetes detection and management among insured adults
Dall et al. Population Health Metrics (2016) 14:43 DOI 10.1186/s12963-016-0110-4 RESEARCH Type 2 diabetes detection and management among insured adults Timothy M. Dall 1*, Weyna Yang 2, Pragna Halder 2,
More informationThe business case for workplace HIV programmes
The business case for workplace HIV programmes Dr. Gesine Meyer-Rath Health Economics and Epidemiology Research Office (HE 2 RO) Department of Internal Medicine, Faculty of Health Sciences, University
More informationOBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
OBSERVATIONAL Patient-centered observational analytics: New directions toward studying the effects of medical products Patrick Ryan on behalf of OMOP Research Team May 22, 2012 Observational Medical Outcomes
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationThe Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University
The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University Expert Opinions CCS Vancouver, BC October 23, 2011 Overview of ACS Epidemiology: Global
More informationhad non-continuous enrolment in Medicare Part A or Part B during the year following initial admission;
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries Weiss J P, Saynina O, McDonald K M, McClellan M
More informationANALYSIS OF KENTUCKY MEDICAID MANAGED CARE VERSUS FEE-FOR- SERVICE SYSTEMS: MEDICATION ADHERENCE IN PATIENTS WITH PREVALENT CHRONIC DISEASES
University of Kentucky UKnowledge Theses and Dissertations--Pharmacy College of Pharmacy 2016 ANALYSIS OF KENTUCKY MEDICAID MANAGED CARE VERSUS FEE-FOR- SERVICE SYSTEMS: MEDICATION ADHERENCE IN PATIENTS
More informationThe hepatitis C virus (HCV) is a major cause of chronic liver disease
Absenteeism and Productivity Among Employees Being Treated for Hepatitis C Richard A. Brook, MS, MBA; Nathan L. Kleinman, PhD; Jun Su, MD, MSc; Patricia K. Corey-Lisle, PhD; and Uchenna H. Iloeje, MD,
More informationNATIONAL HEALTH POLICY FORUM
NATIONAL HEALTH POLICY FORUM UTILIZATION PATTERNS IN ADVANCED IMAGING: THE RADIOLOGY BENEFIT MANAGEMENT EXPERIENCE Susan Nedza, MD, MBA, FACEP Chief Medical Officer AIM Specialty Health / WellPoint, Inc.
More informationUnitedHealth Premium Program Case-mix, Severity and Risk
UnitedHealth Premium Program Case-mix, Severity and Risk Resources u Phone: 866-270-5588 u u Website: UnitedHealthPremium.UHC.com Mail: UnitedHealthcare - UnitedHealth Premium Program MN017-W700 9700 Health
More informationCommercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D.
Commercial Health Insurance Claims Data for Studying HIV/AIDS Care David D. Dore, PharmD, PhD Senior Scientist, Innovus Epidemiology Adjunct Assistant Professor, Alpert Medical School, Brown University
More information5. MEDICARE COVERAGE OF SCREENING FOR OPEN-ANGLE GLAUCOMA. Costs to Medicare
5. MEDICARE COVERAGE OF SCREENING FOR OPEN-ANGLE GLAUCOMA Costs to Medicare At present, neither screening for all people with high intraocular pressure (IOP) nor for those with only manifest open-angle
More informationTuning Epidemiological Study Design Methods for Exploratory Data Analysis in Real World Data
Tuning Epidemiological Study Design Methods for Exploratory Data Analysis in Real World Data Andrew Bate Senior Director, Epidemiology Group Lead, Analytics 15th Annual Meeting of the International Society
More informationAnalysis and Interpretation of Data Part 1
Analysis and Interpretation of Data Part 1 DATA ANALYSIS: PRELIMINARY STEPS 1. Editing Field Edit Completeness Legibility Comprehensibility Consistency Uniformity Central Office Edit 2. Coding Specifying
More informationLow Back Pain Report October 2013: Cost and Utilization of Health Care in Oregon
Low Back Pain Report October 2013: Cost and Utilization of Health Care in Oregon INTRODUCTION Most people in the United States will experience low back pain at least once during their lives. According
More informationCorporate Presentation. August 2016
v Corporate Presentation August 2016 Safe harbor statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
More informationGuideline to Creating a Netball Club
Guideline to Creating a Netball Club Glossary Codes of Behaviour: Netball Queensland has provided templates for the development of Codes of Behaviour for players, parents, coaches and officials. These
More information36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018
36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section
More informationIssue Brief. Coverage Matters: The Role of Insurance in Access to Dental Care in California. Introduction
Coverage Matters: The Role of Insurance in Access to Dental Care in California C ALIFORNIA HEALTHCARE FOUNDATION Introduction Dental insurance is the key to good oral health. People without dental insurance
More informationMichigan s Diabetes Crisis: Today and Future Trends. Dr. William Rowley Institute for Alternative Futures
Michigan s Diabetes Crisis: Today and Future Trends Dr. William Rowley Institute for Alternative Futures 1 What s Happening to Our Children? During their lifetimes: 1/2 will become obese 1 in 3 males &
More informationMaking Diabetes Prevention a Reality: The National Diabetes Prevention Program
Making Diabetes Prevention a Reality: The National Diabetes Prevention Program Ann Albright, PhD, RD Director, Division of Diabetes Translation Centers for Disease Control and Prevention National Center
More informationPrecise Disease Classification Optimizes Bundled Payments. Session #99, March 7, 2018 Stuart Goldberg MD and Andrew Pecora MD
Precise Disease Classification Optimizes Bundled Payments Session #99, March 7, 2018 Stuart Goldberg MD and Andrew Pecora MD 1 Conflict of Interest Stuart L Goldberg MD Salary: Cota Inc. Ownership Interests:
More informationMANAGED DENTAL CARE: PRACTICE OF DENTISTRY. Overview of Benefit Issues. Changes in the Delivery of Dental Benefits FEE-FOR-SERVICE
Managed Care: Dentistry June 25, 23 PRACTICE OF DENTISTRY (BUSINESS ASPECT) VS. Overview of Benefit Issues PRACTICING DENTISTRY (PROFESSIONAL ASPECT) Changes in the Delivery of Dental Benefits Indemnity
More information